QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao, Fei Ye, Miao Zhang et al. · Clinical Infectious Diseases · 2020 · 2.8K citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

Nicholas J. Mercuro, Christina Yen, David Shim et al. · JAMA Cardiology · 2020 · 720 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patients

G. Neal Kay, Plumb Vance J., Arciniegas Joaquin G. et al. · Journal of the American College of Cardiology · 1983 · 464 citations

Medicine, Cardiology, Neurology +3

Long QT Syndrome in Adults

Andrew J. Sauer, Arthur J. Moss, Scott McNitt et al. · Journal of the American College of Cardiology · 2007 · 413 citations

Medicine, Cardiology, Internal Medicine +5